Precision Medicine Intervention in Severe Asthma (PRISM) study: molecular phenotyping of patients with severe asthma and response to biologics

Severe asthma represents an important clinical unmet need despite the introduction of biologic agents. Although advanced omics technologies have aided researchers in identifying clinically relevant molecular pathways, there is a lack of an integrated omics approach in severe asthma particularly in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Hyang, Dixey, Piers, Bhavsar, Pank, Raby, Katie, Kermani, Nazanin, Chadeau-Hyam, Marc, Adcock, Ian M., Song, Woo-Jung, Kwon, Hyouk-Soo, Lee, Sei-Won, Sook Cho, You, Fan Chung, Kian, Kim, Tae-Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Study Protocols
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086686/
https://www.ncbi.nlm.nih.gov/pubmed/37057090
http://dx.doi.org/10.1183/23120541.00485-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086686/
https://www.ncbi.nlm.nih.gov/pubmed/37057090
http://dx.doi.org/10.1183/23120541.00485-2022

Ejemplares similares